Know-How Protection in Pharmaceutical Companies

Four years have passed since the first proposal of the strategic plan Made in China 2025 (MiC 2025). Although China is toning down the public media coverage and official statements regarding the MiC 2025, the plan is still running. Its goals focus on high-tech areas, including the pharmaceutical industry. The MiC 2025 plan sets ambitious… Continue reading Know-How Protection in Pharmaceutical Companies

Reorganization of GI Protection in China

China’s administrative system for IP protection is currently in the state of reorganization and consolidation into one head organization, CNIPA (China National IP Administration). This means certain delays in processing of particular IP issues – e.g., awarding the status of Famous Trademark has been factually postponed for nearly a year now. Another area that is… Continue reading Reorganization of GI Protection in China